OOIR: Observatory of International Research

Papers

(The H4-Index of International Journal of Gynecological Cancer is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Pelvic lymph node decidua mimicking metastatic cervical cancer in pregnancy	326
Inguinofemoral lymphadenectomy technique in 10 steps	153
The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women’s cancer research organization	145
The Cukurova score in the prediction of primary cytoreduction in ovarian cancer	112
Successful cervical cancer treatment during a monochorionic diamniotic twin pregnancy in a patient with history of preterm delivery	103
Correction: SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer	80
Management of stage III and IVa uterine cancer	76
Well-differentiated papillary mesothelial tumor of the peritoneum	66
Complementary use of indocyanine green and technetium to enhance sentinel lymphadenectomy in vulvar cancer	63
A population-based study of outcomes in adjuvant radiotherapy for stage II endometrial carcinoma	58
Survey on implementation of molecular testing in ovarian cancer and PARP inhibitor: a national North-Eastern German Society of Gynecologic Oncology/Young Academy of Gynecologic Oncology/Arbeitsgemeins	57
Surgical technique and surgeon volume: the pursuit of data-driven outcomes	51
Surgical staging for locally-advanced cervical cancer: the answer remains ‘NO’	49
Primary ovarian leiomyosarcoma: results from an analysis by the French Sarcoma Group (Ovarian SArcoma MAnagement – OSAMA Study)	47
Patterns of care and development of quality indicators in patients with non-epithelial and rare ovarian tumors in Australia: insights from the National Gynae-Oncology Registry	46
Epithelial ovarian cancer and borderline tumors during pregnancy: a report from the International Network on Cancer, Infertility, and Pregnancy	45
Utilization of artificial intelligence to mitigate health inequalities in gynecological cancer care	45
22nd meeting of the European Society of Gynaecological Oncology (ESGO 2021) report	45
A fully next-generation sequencing-based method of classifying molecular sub-types of endometrial cancer retains prognostic value and expands biomarker targets	42
PARSGO and UM6SS: spearheading excellence in gynecological oncology in Morocco	42
Correspondence on “Immune checkpoint inhibitor combinations for patients with advanced endometrial cancer: a network meta-analysis and cost-utility analysis” by Zhu and colleagues	42
Erratum to ‘Controversies in vulvar cancer: revisiting the margin of error’ [International Journal of Gynecological Cancer Volume 35 Issue 3 (2025) 101678]	41
Pocket guide based on the TNM and FIGO staging systems for classifying patients with locally advanced cervical cancer: a practical tool from the GINECO group for quick and easy management	40
Best original research presented at the 25th European Congress on Gynaecological Oncology: best of ESGO 2024	40
O021/#374 Breast cancer patients are at increased risk of devoleping uterine serous cancer: implication for conseling – a seer analysis	39

Authors’ response to: “Methodological concerns regarding AGO score validation in low-grade ovarian cancers”	38
Use of quadratus lumborum block in gynecologic procedures	37
Delivery of hereditary cancer genetics services to patients newly diagnosed with ovarian and endometrial cancers at three gynecologic oncology clinics in the USA, Brazil, and Mexico	36
Homologous Recombination Deficiency (HRD) In P53 Abnormal Endometrial Carcinoma	35
Survival impact of histological response to neoadjuvant chemotherapy according to number of cycles in patients with advanced ovarian cancer	35
Vaginal cuff brachytherapy for endometrial cancer: a review of major clinical trials with a focus on fractionation	34
Role of minimally invasive secondary cytoreduction in patients with recurrent ovarian cancer	34
Patient-initiated follow-up in low-risk endometrial cancer after surgery: a systematic review	33